Dose effect evaluation and therapeutic window of the Neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Teste, Iliana Sosa ^a   Tamos, Yuneidys Mengana ^a   Cruz, Yamila Rodríguez ^b   Cernada, Adriana Muñoz ^c   Rodrguez, Janette Cruz ^d   Martnez, Nelvis Subirós ^e   Antich, Rosa Maria Coro ^e   González Quevedo, Alina ^e   Rodríguez, Julio Cesar García ^a  

^a National Center   (Cuba)

^b Histology Department   (Cuba)

^c CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^d CENTRO DE INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS CIDEM   (Cuba)

^e INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

NEURO EPO; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; EPO PROTEIN, HUMAN; ERYTHROPOIETIN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; GERBIL; HIPPOCAMPAL CA3 REGION; MALE; MONGOLIAN GERBIL; NEUROPROTECTION; NONHUMAN; THALAMUS NUCLEUS; ANIMAL; DISEASE MODEL; DOSE RESPONSE; HUMAN; INTRANASAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; GERBILLINAE; HUMANS; NEUROPROTECTIVE AGENTS; TREATMENT OUTCOME;

EID: 84862311297     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/607498     Document Type: Article

References (73)

1. Fisher M., The target of acute stroke therapy and neuroprotective therapeutic approaches Revista de Neurologia 1999 29 6 536 544 (Pubitemid 29505764)
2. Bacigaluppi M., Hermann D. M., New targets of neuroprotection in ischemic stroke TheScientificWorldJournal 2008 8 698 712 (Pubitemid 352000020)
3. Garca-Salman J. D., Endogenous neuronal protection: an alternative approach Revista de Neurologia 2004 38 2 150 155
4. Belayev L., Khoutorova L., Zhao W., Vigdorchik A., Belayev A., Busto R., Magal E., Ginsberg M. D., Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats Stroke 2005 36 5 1071 1076
5. Catania M. A., Marciano M. C., Parisi A., Sturiale A., Buemi M., Grasso G., Squadrito F., Caputi A. P., Calapai G., Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils European Journal of Pharmacology 2002 437 3 147 150 (Pubitemid 34219475)
6. Sirén A. L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., Ghezzi P., Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4044 4049 (Pubitemid 32249895)
7. Leist M., Ghezzi P., Grasso G., Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 2004 305 5681 239 242 (Pubitemid 38886736)
8. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S., Sasaki R., Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery Biochemical and Biophysical Research Communications 1998 253 1 26 32 (Pubitemid 29015594)
9. Hermann D. M., Enhancing the delivery of erythropoietin and its variants into the ischemic brain TheScientificWorldJournal 2009 9 967 969
10. Sirén A. L., Knerlich F., Poser W., Gleiter C. H., Brck W., Ehrenreich H., Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain Acta Neuropathologica 2001 101 3 271 276 (Pubitemid 32219761)
11. Ehrenreich H., Nau R., Dembowski C., Hasselblatt M., Barth M., Hahn A., Schilling L., Sirén A. L., Brck W., Endothelin B receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus Neuroscience 1999 95 4 993 1001 (Pubitemid 30006887)
12. Brines M., Cerami A., Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response Journal of Internal Medicine 2008 264 5 405 432
13. Muoz-Cernuda A., Len-Rodrguez R., Garca-Rodrguez J., Formulaciones nasales de EPOhr con bajo contenido de cido silico para el tratamiento de enfermedades del Sistema Nervioso Central. (20050138) Patent Cuba, 722, 2005
14. Cerami A., Brines M. L., Ghezzi P., Cerami C. J., Effects of epoetin alfa on the central nervous system Seminars in Oncology 2001 28 supplement 8 66 70 (Pubitemid 32522241)
15. Cerami A., Brines M., Ghezzi P., Cerami C., Itri L. M., Neuroprotective properties of epoetin alfa Nephrology Dialysis Transplantation 2002 17 1 8 12 (Pubitemid 34157113)
16. Li Y., Lu Z., Keogh C. L., Yu S. P., Wei L., Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice Journal of Cerebral Blood Flow Metabolism 2007 27 5 1043 1054 (Pubitemid 46659037)
17. Sirén A. L., Fahauer T., Bartels C., Ehrenreich H., Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system Neurotherapeutics 2009 6 1 108 127
18. Dame C., Juul S. E., Christensen R. D., The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential Biology of the Neonate 2001 79 3-4 228 235 (Pubitemid 32247092)
19. Kabanov A. V., Batrakova E. V., New technologies for drug delivery across the blood brain barrier Current Pharmaceutical Design 2004 10 12 1355 1363 (Pubitemid 38578372)
20. Banks W. A., Are the extracellular pathways a conduit for the delivery of therapeutics to the brain? Current Pharmaceutical Design 2004 10 12 1365 1370 (Pubitemid 38559752)
21. Kalialis L., Olsen N., Erythropoietina new therapy in cerebral ischemia? Ugeskr Laeger 2003 165 24 2477 2481 (Pubitemid 38094585)
22. Marti H. H., Erythropoietin gene expression in human, monkey and murine brain European Journal of Neuroscience 1996 8 4 666 676 (Pubitemid 26114611)
23. Banks W. A., During M. J., Niehoff M. L., Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration Journal of Pharmacology and Experimental Therapeutics 2004 309 2 469 475 (Pubitemid 38542596)
24. Erbayraktar S., Yilmaz O., Erythropoietin is a multifunctional tissue-protective cytokine Current Hematology Reports 2003 2 6 465 470
25. Nagai A., Nakagawa E., Choi H. B., Hatori K., Kobayashi S., Kim S. U., Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture Journal of Neuropathology and Experimental Neurology 2001 60 4 386 392 (Pubitemid 32274054)
26. Wiessner C., Allegrini P. R., Ekatodramis D., Jewell U. R., Stallmach T., Gassmann M., Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin Journal of Cerebral Blood Flow Metabolism 2001 21 7 857 864 (Pubitemid 32613540)
27. Jelkmann W., Molecular biology of erythropoietin Internal Medicine 2004 43 8 649 659 (Pubitemid 39264162)
28. Yu Y. P., Xu Q. Q., Zhang Q., Zhang W. P., Zhang L. H., Wei E. Q., Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia Neuroscience Letters 2005 387 1 5 10 (Pubitemid 41138199)
29. Mostacero E., Neurotoxicity, neuroprotection and therapeutic window in the cerebral ischemia Revista de Neurologia 1999 29 6 513 514 (Pubitemid 29505759)
30. Cotena S., Piazza O., Tufano R., The use of erythtropoietin in cerebral diseases Panminerva Medica 2008 50 2 185 192
31. Consejo Canadiense de Proteccin de los animales, Guidelines for Breeding and Care of Laboratory Animals. World Health Organization and Institucional Council for Laboratory Animals Science (ICLAS), 1998
32. Sosa Testé I., Garca Rodrguez J. C., Garca Salman J. D., Intranasal administration OF recombinant human erythropoietin exerts neuroprotective effects on post-ischemic brain injury in mongolian gerbils PharmacologyOnline 2006 1 100 112
33. Butterfield J. D., McGraw C. P., Effect of DPPD (diphenyl-para- phenylenediamine) on stroke and cerebral edema in gerbils Stroke 1978 9 5 480 483 (Pubitemid 8389077)
34. Lawner P., Laurent J., Simeone F., Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil Stroke 1979 10 6 644 647 (Pubitemid 10203454)
35. Rodrguez Cruz Y., Mengana Tmos Y., Muoz Cernuda A., Subirs Martines N., Gonzlez-Quevedo A., Sosa Testé I., Garca Rodrguez J. C., Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia TheScientificWorldJournal 2010 10 2288 2300
36. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M. L., Ghezzi P., Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis Brain Research 2002 952 1 128 134 (Pubitemid 35279495)
37. Erbayraktar S., Grasso G., Sfacteria A., Xie Q. W., Coleman T., Kreilgaard M., Torup L., Sager T., Erbayraktar Z., Gokmen N., Yilmaz O., Ghezzi P., Villa P., Fratelli M., Casagrande S., Leist M., Helboe L., Gerwein J., Christensen So. S.., Geist M. A., Pedersen L.., Cerami-Hand C., Wuerth J. P., Cerami A., Brines M., Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6741 6746 (Pubitemid 36666650)
38. Fisher M., Recommendations for standards regarding preclinical neuroprotective and restorative drug development Stroke 1999 30 12 2752 2758
39. Hossmann K. A., Pathophysiology and therapy of experimental stroke Cellular and Molecular Neurobiology 2006 26 7-8 1057 1083
40. Traystman R. J., Animal models of focal and global cerebral ischemia ILAR Journal 2003 44 2 85 95 (Pubitemid 36410962)
41. Pelliccioli G. P., Gambelunghe C., Ottaviano P. F., Iannaccone S., Ambrosini M. V., Variable response of the Mongolian gerbil to unilateral carotid occlusion: magnetic resonance imaging and neuropathological characterization The Italian Journal of Neurological Sciences 1995 16 7 517 526
42. Somova L. I., Gregory M. A., Nxumalo E. N., Mongolian gerbil (Meriones unguiculatus) as a model of cerebral infarction for testing new therapeutic agents Methods and Findings in Experimental and Clinical Pharmacology 2000 22 4 203 210 (Pubitemid 30451550)
43. Babcock M., Baker D. A., Lovec R., Locomotor activity in the ischemic gerbil Brain Research 1993 625 2 351 354 (Pubitemid 23300436)
44. Payan H. M., Conard J. R., Carotid ligation in gerbils. Influence of age, sex, and gonads Stroke 1977 8 2 194 196 (Pubitemid 8078355)
45. Torup L., Leist M., Development of non-erythropoietic erythropoietin variants for neuroprotection Erythropoietin and the Nervous System 2006 New York, NY, USA Springer
46. Graham S. M., McCullough L. D., Murphy S. J., Animal models of ischemic stroke: balancing experimental aims and animal care Comparative Medicine 2004 54 5 486 496 (Pubitemid 39557442)
47. Juul S. E., Anderson D. K., Li Y., Christensen R. D., Erythropoietin and erythropoietin receptor in the developing human central nervous system Pediatric Research 1998 43 1 40 49 (Pubitemid 28069166)
48. Chopp M., Li Y., Zhang J., Plasticity and remodeling of brain Journal of the Neurological Sciences 2008 265 1-2 97 101
49. Boroojerdi B., Ziemann U., Chen R., Btefisch C. M., Cohen L. G., Mechanisms underlying human motor system plasticity Muscle and Nerve 2001 24 5 602 613 (Pubitemid 32373021)
50. Ehrenreich H., Bartels C., Sargin D., Stawicki S., Krampe H., Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition Journal of Renal Nutrition 2008 18 1 146 153 (Pubitemid 350251844)
51. Kirino T., Tamura A., Sano K., Delayed neuronal death in the rat hippocampus following transient forebrain ischemia Acta Neuropathologica 1984 64 2 139 147 (Pubitemid 14096059)
52. Kirino T., Sano K., Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus Acta Neuropathologica 1984 62 3 209 218 (Pubitemid 14178597)
53. Colbourne F., Li H., Buchan A. M., Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats Stroke 1999 30 3 662 668 (Pubitemid 29115408)
54. Halsey J. H., Capra N. F., McFarland R. S., Use of hydrogen for measurement of regional cerebral blood flow: problem of intercompartmental diffusion Stroke 1977 8 3 351 357 (Pubitemid 8103615)
55. Xiong Y., Mahmood A., Qu C., Kazmi H., Zhang Z. G., Noguchi C. T., Schallert T., Chopp M., Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor Journal of Neurotrauma 2010 27 1 205 215
56. Sanchez P. E., Fares R. P., Risso J. J., Bonnet C., Bouvard S., Le-Cavorsin M., Georges B., Moulin C., Belmeguenai A., Bodennec J., Morales A., Pequignot J. M., Baulieu E. E., Levine R. A., Bezin L., Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons Proceedings of the National Academy of Sciences of the United States of America 2009 106 24 9848 9853
57. Gao Y., Mengana Y., Cruz Y. R., Muoz A., Testé I. S., Garca J. D., Wu Y., Rodrguez J. C.G., Zhang C., Different expression patterns of ngb and epor in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of neuro-epo for ischemic insults to the gerbil brain Journal of Histochemistry and Cytochemistry 2011 59 2 214 227
58. Bernaudin M., Marti H. H., Roussel S., Divoux D., Nouvelot A., MacKenzie E. T., Petit E., A potential role for erythropoietin in focal permanent cerebral ischemia in mice Journal of Cerebral Blood Flow Metabolism 1999 19 6 643 651 (Pubitemid 30161216)
59. Fisher M., Bastan B., Treating acute ischemic stroke Current Opinion in Drug Discovery and Development 2008 11 5 626 632
60. Thorne R. G., Emory C. R., Ala T. A., Frey W. H., Quantitative analysis of the olfactory pathway for drug delivery to the brain Brain Research 1995 692 1-2 278 282
61. Hossmann K. A., Experimental models for the investigation of brain ischemia Cardiovascular Research 1998 39 1 106 120
62. Ginsberg M. D., Neuroprotection for ischemic stroke: past, present and future Neuropharmacology 2008 55 3 363 389
63. Lapchak P. A., Araujo D. M., Advances in ischemic stroke treatment: neuroprotective and combination therapies Expert Opinion on Emerging Drugs 2007 12 1 97 112 (Pubitemid 46499497)
64. Micieli G., Marcheselli S., Tosi P. A., Safety and efficacy of alteplase in the treatment of acute ischemic stroke Vascular Health and Risk Management 2009 5 397 409
65. Dame C., Fahnenstich H., Don't give up on erythropoietin as a neuroprotective agent Pediatrics 2005 116 2 521 522 (Pubitemid 44161498)
66. Tsai P. T., Ohab J. J., Kertesz N., Groszer M., Matter C., Gao J., Liu X., Wu H., Carmichael S. T., A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery Journal of Neuroscience 2006 26 4 1269 1274 (Pubitemid 43237059)
67. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M., Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 2004 35 7 1732 1737 (Pubitemid 38823656)
68. Villa P., Van Beek J., Larsen A. K., Gerwien J., Christensen S., Cerami A., Brines M., Leist M., Ghezzi P., Torup L., Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives Journal of Cerebral Blood Flow Metabolism 2007 27 3 552 563
69. Rodrguez J. C. G., Teste I. S., The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans TheScientificWorldJournal 2009 9 970 981
70. Minnerup J., Heidrich J., Rogalewski A., Schbitz W. R., Wellmann J., The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis Stroke 2009 40 9 3113 3120
71. Fantacci M., Bianciardi P., Caretti A., Coleman T. R., Cerami A., Brines M., Samaja M., Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17531 17536 (Pubitemid 44789003)
72. Fiordaliso F., Chimenti S., Staszewsky L., Bai A., Carlo E., Cuccovillo I., Doni M., Mengozzi M., Tonelli R., Ghezzi P., Coleman T., Brines M., Cerami A., Latini R., A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury Proceedings of the National Academy of Sciences of the United States of America 2005 102 6 2046 2051 (Pubitemid 40262009)
73. Mintorovitch J., Yang G. Y., Shimizu H., Kucharczyk J., Chan P. H., Weinstein P. R., Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na +,K + -ATPase activity Journal of Cerebral Blood Flow Metabolism 1994 14 2 332 336 (Pubitemid 24064446)